| P243 |
Free cortisol index in suspected
HPA axis pathology |
|
LeRoux C, Dhillo W, Kong WM,
Chapman G, Jones J & Alaghband Zadeh J |
| |
|
| P244 |
Expression and corticosteroid regulation
of serum and glucocorticoid regulated kinase, and epithelial sodium channel
subunits in human ocular ciliary epithelium |
|
Rauz S, Walker EA, Hughes SV,
Coca-Prados M, Hewison M, Murray PI & Stewart PM |
| |
|
| P245 |
Carbenoxolone, an inhibitor of 11b-hydroxysteroid
dehydrogenase type 1, reduces intraocular pressure in patients with ocular
hypertension |
|
Cheung CMG, Rauz S, Murray PI & Stewart
PM |
| |
|
| P246 |
Comparison of the efficacy of long-term
self-administration of subcutaneous human chorionic gonadotrophin with
intramuscular exogenous testosterone (Sustanon) in male hypogonadism |
|
Caddy SJ & Jones TH |
| |
|
| P247 |
The prevalence and morbidity of
long-term oral corticosteroid therapy |
|
Mackie JH, Cooper MS & Stewart
PM |
| |
|
| P248 |
The relationship between smoking,
statin therapy and testosterone in men with coronary artery disease |
|
Morris PD, Pugh PJ, Hall J, Channer
KS & Jones TH |
| |
|
| P249 |
Androgens and diabetes mellitus
in men with coronary artery disease |
|
Morris PD, Pugh PJ, Roberts SA,
Channer KS & Jones TH |
|
|
| P250 |
Testosterone and pro-inflammatory
cytokines in men with chronic heart failure |
|
Hall J, Pugh PJ, Jones RD, Corlett
G, Channer KS & Jones TH |
| |
|
| P251 |
Testosterone therapy improves depressive
symptoms in men with chronic heart failure |
|
Pugh PJ, Jones RD, Hall J, Channer
KS & Jones TH |
| |
|
| P252 |
Testosterone increases interleukin
10, an anti-inflammatory cytokine, in whole blood from hypogonadal men |
|
Corlett GL, Pugh PJ, Kapoor D,
Jones RD, Channer KS & Jones TH |
| |
|
| P253 |
Testosterone and skeletal muscle
parameters in men with chronic heart failure |
|
Pugh PJ, Jones RD, Hall J, Channer
KS, Jones TH & van Beek E |
| |
|
| P254 |
Hypoglycaemia and Addisons
disease - cause or association? |
|
Kennedy A, Hadden DR & Hunter
SJ |
| |
|
| P255 |
Intermittent hyponatraemia due to
isolated ACTH deficiency |
|
Ajjan R, Scott E, Ismail A, Walker
P & Nagi DK |
| |
|
| P256 |
Expression of adipose 11b-hydroxysteroid
dehydrogenase type 1 in human obesity |
|
Tomlinson JW, Sinha B, Hewison
M & Stewart PM |
| |
|
| P257 |
Enhanced hepatic A-ring reduction
of glucocorticoids in obesity: regulation by glucocorticoids and insulin |
|
Livingstone DEW, McInnes KJ,
Walker BR & Andrew R |
| |
|
| P258 |
In vitro expression of catalytically
active human aldosterone synthase |
|
Inglis GC, Davies E, Stewart
PM, Fraser R & Connell JMC |
| |
|
| P259 |
Reduced glucocorticoid receptor
expression in obese Zucker rats: protection from the metabolic consequences
of obesity? |
|
Drake AJ, Cleasby ME, Livingstone
DEW, Seckl JR & Walker BR |
| |
|
| P260 |
Assessment of mineralocorticoid
status by urinary corticosteroid profiling using gas chromatography-mass
spectrometry (GCMS) |
|
Shakerdi L, Fraser R & Wallace
AM |
| |
|
| P261 |
Angiotensin II and ACTH differentially
regulate adrenal steroid production through key steroidogenic enzymes |
|
Kelly SN, Smith TP, Cunningham
SK, Young LS & McKenna TJ |
| |
|
| P262 |
A role for nur-77 in the regulation of adrenal
steroid production |
|
Kelly SN, Smith TP, Cunningham SK, McKenna
TJ & Young LS |
| |
|
| P263 |
Growth hormone increases fat mass in patients
with simple obesity |
|
Tomlinson JW, Crabtree N, Clark PMS, Holder
G, Shackleton CHL & Stewart PM |
| |
|
| P264 |
Cortisone reductase (11b-hydroxysteroid
dehydrogenase type 1) deficiency presenting with features of late onset
congenital adrenal hyperplasia |
|
Laing I, Adams JE, Wood PJ, Taylor NF & Ray
DW |
| |
|
| P265 |
Phytoestrogen dietary supplementation does not
alter serum IGF-1 levels in postmenopausal women |
|
Jayagopal V, Albertazzi P, Kilpatrick ES,
Jennings PE & Atkin SL |
| |
|
| P266 |
Testosterone exhibits a calcium antagonistic
action upon store operated calcium channels in cultured vascular smooth
muscle cells |
|
Jones RD, Ruban LN, Pugh PJ, English KM, Channer
KS & Jones TH |
| |
|
| P267 |
Testosterone does not increase the production
of cyclic AMP (cAMP) in cultured vascular smooth muscle cells |
|
Ruban LN, Jones RD, Pugh PJ, English KM, Channer
KS & Jones TH |
| |
|
| P268 |
Circulating steroid levels in the testicular
feminised (Tfm) mouse |
|
Jones RD, Hall J, Pugh PJ, English KM, Channer
KS & Jones TH |
| |
|
| P269 |
Size at birth, gestational age and cortisol secretion
in adult life: do multiple mechanisms underlie fetal programming of the
hypothalamic-pituitary-adrenal axis? |
|
Kajantie E, Phillips DIW, Dunkel L, Andersson
S, Barker DJP, Forsen T, Osmond C, Wood PJ, Tuominen J & Eriksson
J |
| |
|
| P270 |
Roles of k-ras and Gadd153 in 17b-oestradiol-induced
apoptosis in colo205 cells |
|
Qiu Y, Langman MJS & Eggo MC |
| |
|
| P271 |
Fetal and maternal regulation of aldosterone
synthase and 11b-hydroxylase |
|
Lo YC, Mason JI, Williams BC, Lloyd-MacGilp
SA & Kenyon CJ |
| |
|
| P272 |
Quantification of aldosterone synthase
(CYP11B2) gene expression in the adrenal gland and central nervous
system following dietary sodium manipulation |
|
Ye P, Kenyon CJ, Mackenzie SM,
Fraser R, Connell JMC & Davies E |
| |
|
| P273 |
Long-term overall success after
transsphenoidal surgery for Cushings disease: time for a reappraisal
of therapy? |
|
Kennedy A, Wiggam MI, Hadden
DR, McCance DR, Sheridan B & Atkinson AB |
| |
|
| P274 |
What value do cortisol measurements
provide in monitoring metyrapone therapy? |
|
Wieringa G, Naing S, Perry LA,
Anderson JM, Wiener K, Burrows GC, Warburton R, Kane JW & Trainer
PJ |
| |
|
Thyroid |
| P275 |
Atrial fibrillation predicts mortality
in thyrotoxicosis |
|
Osman F, Daykin J, Sheppard MC,
Gammage MD & Franklyn JA |
| |
|
| P276 |
Increased force/unit cross sectional
area as well as increased bulk causes recovery in proximal strength in
hyper/hypothyroidism |
|
Khaleeli AA & Houghton T |
| |
|
| P277 |
Influence of pre-treatment factors
on outcomes following the use of high fixed dose radioiodine treatment
for hyperthyroidism |
|
Barton DM, Buch HN, Baskar V,
Kumar H & West TET |
| |
|
| P278 |
The female preponderance to autoimmune
thyroid disease is reduced in multiplex type 1 diabetes families |
|
Tait KF, Berman J, Carr-Smith
J, Rowe B, Heward JM, Franklyn JA, Todd JA, Bain SC, Barnett AH & Gough
SCL |
| |
|
| P279 |
Analysis of a clinical workstation
thyrotoxicosis share-care scheme |
|
Chatterjee S, Kieffer V & Howlett
TA |
| |
|
| P280 |
Thyrotoxic heart failure in a previously
fit 40 year old woman |
|
Banerjee M, Javaid K, Khan S & Vice
PA |
| |
|
| P281 |
Delayed resolution of endothelial
dysfunction despite biochemical correction of thyrotoxicosis |
|
Obuobie K, Evans SA & Lazarus
JH |
| P282 |
Thyroid function in paediatric patients
with malignancy after radiotherapy in Isfahan, Iran |
|
Hashemipoor M, Golpaiegani F,
Babazadeh S, Maafi AR, Javanmardy GA & Iranpour R |
| |
|
| P283 |
Thyroid hormone (TH) regulation
of iodothyronine deiodinase and thyroid hormone receptor (TR) expression
in placental trophoblast cells |
|
Hobbs EL, Driver P, McCabe CJ,
Franklyn JA & Kilby MD |
| |
|
| P284 |
Pituitary tumor transforming gene
and basic fibroblast growth factor-2 - novel potential molecular indicators
for thyroid cancer |
|
Boelaert K, McCabe CJ, Tannahill
LA, Gittoes NJL, Eggo MC, Watkinson JC, Sheppard MC & Franklyn JA |
| |
|
| P285 |
Outcome at two years of fixed dose
radioiodine treatment for thyrotoxicosis |
|
Forde I, Corgie D & Trainer
PJ |
| |
|
| P286 |
Effect of blood exchange transfusion
on neonatal thyroid function |
|
Iranpour R, Hashemipoor M, Haghshenas
I, Hamidi M & Heydarzadeh A |
| |
|
| P287 |
Provision of a new strength thyroxine
tablet would facilitate tight control of TSH concentrations in primary
hypothyroidism |
|
Bhala N, Weetman AP & Jenkins
RC |
| |
|
| P288 |
The follow-up status of patients
10 years after treatment with radioactive iodine (RI) for hyperthyroidism |
|
Varghese B & Trainer PJ |
|
|
| P289 |
A cluster of cases of subacute thyroiditis
in north east England |
|
Craig FE, Frewin S & Perros
P |
| |
|
| P290 |
Audit of the management of maternal
hypothyroidism in pregnancy: implications for service provision |
|
Hannon T, Sturgiss S & Ball
SG |
| |
|
| P291 |
Lithium associated thyrotoxicosis |
|
Ghosh S & Bangar V |
| |
|
| P292 |
Thyroid dysfunction in diabetes:
can we justify routine screening? |
|
Moulik PK, Nethaji C & Khaleeli
AA |
| |
|
| P293 |
Clinical assessment of two methods
for measuring thyrotropin binding inhibiting immunoglobulin (TBII) |
|
Schardt CW, Perros P, Fleetwood
A, Self C & Weightman DR |
|
|
| P294 |
Thyroid peroxidase antibodies are
not a surrogate for thyroid stimulating antibodies in the investigation
of the etiology of thyrotoxicosis |
|
Evans C, Alkhafaji F, Selwood
C & Ludgate M |
| |
|
| P295 |
Molecular characterisation of congenital
hypothyroidism |
|
Jordan NJ, Gregory J, Evans C,
Williams NM, Owen MJ & Ludgate Mv |
| |
|
| P296 |
Pyrimidine and purine metabolism
in human leukocytes in autoimmunological thyroid diseases - RNA expression
of some enzymes |
|
Lewinski A, Brzezianska E, Karbownik
M, Zasada K, Migdalska-Sek M & Pastuszak-Lewandoska D |
| |
|
| P297 |
Protein kinase C delta interacts
with the sodium iodide symporter (NIS) to increase its activity in human
thyrocytes |
|
Turner FE & Eggo MC |
| |
|
| P298 |
Profile of the thyroid function
in a population with type-2 diabetes mellitus |
|
Nobre EL, Jorge Z, Pratas S,
Silva C & Castro JJ |
| |
|
| P299 |
Thyroid function in early pregnancy.
A prospective study |
|
Bohnet HG & Martens K |
| |
|
| P300 |
Determining the molecular causes
of hyperthyroidism |
|
Al-Khafaji F, Baker G & Ludgate
M |
| |
|
| P301 |
Telephone follow-up following radioiodine
therapy for thyrotoxicosis improves outcome |
|
Murphy E, Mehta S, Gannon D,
Bassett JHD, Frank J & Meeran K |
| |
|
| P302 |
Environmental factors produce variation
within a model of thyroid eye disease |
|
Baker GRC & Ludgate M |
| |
|
| P303 |
The use of lithium as an adjunct
to radioiodine therapy for thyrotoxicosis |
|
Murphy E, Bassett JHD, Frank
J & Meeran K |
| |
|
| P304 |
Adenoviral expression of secreted
Tie-2 reduces thyroid follicular cell growth and adhesion |
|
Ramsden JD, Mautner V, Watkinson
J & Eggo MC |
| |
|
| P305 |
Primary hypothyroidism and unilateral
thyroid eye disease: a case report |
|
Ozgen AG, Terzioglu E, Duman
E & Kabalak T |
|
|
| P306 |
Plasma total and free tissue factor
pathway inhibitor, tissue plasminogen activator antigen, and plasminogen
activator inhibitor antigen levels in various thyroid disorders |
|
Comlekci A, Ozcan MA, Demirkan
F, Sari I, Demir T, Ozsan H, Oruk G & Yesil S |
| |
|
| P307 |
High thyroglobulin autoantibodies
in Sri Lankan Tamil tea workers exhibit an epitope-recognition pattern
distinct from healthy subjects and autoimmune thyroid disease (AITD) patients |
|
Okosieme OE, Parkes AB, Premawardhana
LDKE, Ruf J, Carayon P & Lazarus JH |
| |
|
| P308 |
Thyroid disease in patients with
genetic haemochromatosis - a prospective study |
|
Murphy MS & Walsh CH |